Zydus Lifesciences announced the launch of Anyra, India's first indigenously developed biosimilar of Aflibercept 2 mg, aimed at treating a range of serious retinal disorders.
Nuvama has flagged four pharma stocks as top ‘Buy’ picks, citing strong US launches, biosimilars traction and margin ...
Bristol-Myers Squibb Company hits a 52-week high as Breyanzi sales surge and AI imaging expands. Click for this updated look at BMY stock prospects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results